While CAR T-cell therapy represents a major step forward in the treatment of various blood cancers, there are side effects that need to be addressed. Clinical researchers like Dr. Emily Liang are conducting trials focused on reducing inflammation that leads to side effects like cytokine release syndrome and neurotoxicity. #cartcelltherapy #immunotherapy #cancer #cancertreatment #cancerjourney #bloodcancer #leukemia #lymphoma #myeloma #clinicaltrial #fredhutch #seattle | Fred Hutch

Devex - How can we make advanced therapies such as CAR...

CAR T-cell therapy is a game changer in the treatment of certain types of blood cancers, particularly when other treatments have not been successful or the cancer has relapsed. Dr. Emily Liang explains how the therapy modifies a patient’s own immune cells to better recognize and attack cancer cells. Learn more: https://bit.ly/3MTcwzk #bloodcancerawareness #immunotherapy | Fred Hutch

The Future of CAR T-Cell Treatment